Tempest Therapeutics, Inc. (TPST)

Tempest Therapeutics Statistics

Total Valuation

TPST has a market cap or net worth of $15.32 million. The enterprise value is $16.95 million.

Market Cap	15.32M
Enterprise Value	16.95M

Important Dates

The last earnings date was Wednesday, November 5, 2025, after market close.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

TPST has 4.93 million shares outstanding. The number of shares has increased by 114.19% in one year.

Current Share Class	4.93M
Shares Outstanding	4.93M
Shares Change (YoY)	+114.19%
Shares Change (QoQ)	+16.75%
Owned by Insiders (%)	0.13%
Owned by Institutions (%)	5.64%
Float	4.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.39
P/TBV Ratio	2.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.30, with a Debt / Equity ratio of 1.32.

Current Ratio	2.30
Quick Ratio	2.13
Debt / Equity	1.32
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-80.21

Financial Efficiency

Return on equity (ROE) is -405.03% and return on invested capital (ROIC) is -103.58%.

Return on Equity (ROE)	-405.03%
Return on Assets (ROA)	-89.32%
Return on Invested Capital (ROIC)	-103.58%
Return on Capital Employed (ROCE)	-267.69%
Revenue Per Employee	n/a
Profits Per Employee	-$1.50M
Employee Count	24
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.90% in the last 52 weeks. The beta is -2.26, so TPST's price volatility has been lower than the market average.

Beta (5Y)	-2.26
52-Week Price Change	-69.90%
50-Day Moving Average	8.75
200-Day Moving Average	8.47
Relative Strength Index (RSI)	26.32
Average Volume (20 Days)	228,656

Short Selling Information

The latest short interest is 153,644, so 3.12% of the outstanding shares have been sold short.

Short Interest	153,644
Short Previous Month	156,075
Short % of Shares Out	3.12%
Short % of Float	3.30%
Short Ratio (days to cover)	3.93

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-36.42M
Pretax Income	-36.05M
Net Income	-36.05M
EBITDA	-36.17M
EBIT	-36.42M
Earnings Per Share (EPS)	-$9.71

Balance Sheet

The company has $7.51 million in cash and $8.41 million in debt, giving a net cash position of -$891,000 or -$0.18 per share.

Cash & Cash Equivalents	7.51M
Total Debt	8.41M
Net Cash	-891,000
Net Cash Per Share	-$0.18
Equity (Book Value)	6.35M
Book Value Per Share	1.43
Working Capital	4.58M

Cash Flow

In the last 12 months, operating cash flow was -$33.40 million and capital expenditures -$3,000, giving a free cash flow of -$33.40 million.

Operating Cash Flow	-33.40M
Capital Expenditures	-3,000
Free Cash Flow	-33.40M
FCF Per Share	-$6.78

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPST does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-114.19%
Shareholder Yield	-114.19%
Earnings Yield	-224.46%
FCF Yield	-207.92%

Analyst Forecast

The average price target for TPST is $12.50, which is 301.93% higher than the current price. The consensus rating is "Hold".

Price Target	$12.50
Price Target Difference	301.93%
Analyst Consensus	Hold
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 9, 2025. It was a reverse split with a ratio of 1:13.

Last Split Date	Apr 9, 2025
Split Type	Reverse
Split Ratio	1:13

Scores

Altman Z-Score	n/a
Piotroski F-Score	2